Gene splicing gone wrong leads to aggressive medulloblastoma
Disturbing OTX2’s gene-splicing ability reduced tumor growth, opening possibilities for improved treatments.
Read MoreDisturbing OTX2’s gene-splicing ability reduced tumor growth, opening possibilities for improved treatments.
Read MoreResearchers discussed the latest cutting-edge, translational and clinical research focusing on pediatric hematology and oncology.
Read MoreMedulloblastoma is the most common type of solid brain tumor in children. Current treatments offer limited success and may leave patients with severe neurological side
Read More